Evidence map›Paper›PMID 27547489›Full record

ArticleJournal of addiction research & therapy2015

Confounding of the Comparative Safety of Prenatal Opioid Agonist Therapy.

Susan B Brogly, Kristen A Hahn, Sonia Hernandez Diaz, Martha Werler

Open access · hybridAbstract read
In one paragraph

Article in Journal of addiction research & therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Susan B BroglyDepartments of Surgery and of Medicine, Queen's University, Canada.
Kristen A HahnDepartment of Epidemiology, Boston University School of Public Health, USA.
Sonia Hernandez DiazDepartment of Epidemiology, Harvard School of Public Health, USA.
Martha WerlerDepartment of Epidemiology, Boston University School of Public Health, USA.
Boston University · US

Funding

Comparative Safety of Buprenorphine vs. Methadone in PregnancyR21HD081271 · NICHD · QUEEN'S UNIVERSITY AT KINGSTON · PI BROGLY, SUSAN B · 2014 to 2015
$410k
NICHD NIH HHS R21 HD081271PHS HHS
6 · The paper itself

Abstract

Prenatal opioid agonist therapy with methadone or buprenorphine prevents maternal illicit opioid use and withdrawal and improves pregnancy outcomes compared to heroin use alone. Historically, methadone has been the first-line opioid agonist therapy for pregnant opioid dependent women; in recent years buprenorphine has become first-line treatment for some opioid dependent pregnant women. While there is some evidence of better outcomes in neonates exposed to buprenorphine vs. methadone, the effect of confounding from differences in women who use buprenorphine and methadone has not been carefully examined in most studies. This review explores mechanisms by which confounding can arise in measuring associations between prenatal buprenorphine vs. methadone exposure on neonatal outcomes using a graphical approach, directed acyclic graphs. The goal of this paper is to facilitate better understanding of the factors influencing neonatal abstinence syndrome and accurate assessment of the comparative safety of opioid agonist therapies on the neonate.

Indexed as

BuprenorphineConfoundingMethadoneNeonatal abstinence syndromePregnancy

Identifiers

PMID27547489
PMCPMC4991778
OpenAlexW2510448148

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.